Thomas Cummings has extensive experience in nonclinical safety evaluation and operations within the pharmaceutical industry, currently serving as Director of Nonclinical Safety Evaluation Operations at Alkermes since May 2018. In this role, Thomas is responsible for ensuring timely and high-quality deliverables related to nonclinical safety studies, reports, and regulatory submissions, collaborating closely with contract research organizations and toxicologists. Prior to Alkermes, Thomas held various positions at Pfizer from 2000 to 2018, including Senior Scientist and General Toxicology Study Monitor, focusing on managing outsourced drug safety projects and CRO qualifications. Thomas began professional development in the field through a training role within Drug Safety Research and Development. Thomas holds a Bachelor of Science degree in Animal Science from the University of Connecticut, obtained between 1982 and 1986.
This person is not in any teams
This person is not in any offices